STK11 and non-small cell lung carcinoma: Concurrent mutations in certain gene combinations may worsen survival in an additive manner, as is known for STK11 and KEAP1 in NSCLC34 and observed in the MSK-IMPACT NSCLC cohort (Fig. S9B).